Lv41
450 积分 2023-02-16 加入
P911 Development and Characterization of SPY002, a Novel Extended Half-life Monoclonal Antibody Drug Candidate Targeting TL1A for the Treatment of IBD
5小时前
待确认
P911 Development and Characterization of SPY002, a Novel Extended Half-life Monoclonal Antibody Drug Candidate Targeting TL1A for the Treatment of IBD
5小时前
已完结
Targeting the TNF and TNFR superfamilies in autoimmune disease and cancer
5小时前
已完结
A Norrin/Wnt surrogate antibody stimulates endothelial cell barrier function and rescues retinopathy
4个月前
已完结
Interruption of the intratumor CD8+ T cell:Treg crosstalk improves the efficacy of PD-1 immunotherapy
7个月前
已完结
Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8+ T cells to promote antitumor immunity
7个月前
已完结
Malic enzyme 2 maintains metabolic state and anti-tumor immunity of CD8+ T cells
7个月前
已完结
Considerations for the Design of Antibody-Based Therapeutics
1年前
已完结
Neonatal Fc receptor and IgG-based therapeutics
2年前
已完结
CD25-Treg-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity
2年前
已完结
皖公网安备34019202002308
